Improving care for thyroid cancer survivors by assessing their risk of recurrence
Risk-stratified care for thyroid cancer survivors
This study is looking to improve the follow-up care for people who have survived thyroid cancer by finding a better way to understand their chances of the cancer coming back, so they can get the right level of care without unnecessary stress.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11075898 on NIH RePORTER |
What this research studies
This research aims to enhance the care of thyroid cancer survivors by developing a method to better assess their risk of cancer recurrence. By collaborating with various cancer registries and utilizing a comprehensive data collection strategy, the study will gather information from pathology reports, patient reports, and physician records. The goal is to identify which survivors are at higher or lower risk for recurrence and to tailor their follow-up care accordingly, potentially reducing unnecessary surveillance and associated anxiety.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been diagnosed with thyroid cancer and are currently in the survivorship phase.
Not a fit: Patients who have not been diagnosed with thyroid cancer or those who are currently undergoing active treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective follow-up care for thyroid cancer survivors, reducing unnecessary tests and anxiety.
How similar studies have performed: Previous research has shown success in risk stratification approaches for other cancer types, suggesting that this methodology could be effective for thyroid cancer as well.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Haymart, Megan Rist — University of Michigan at Ann Arbor
- Study coordinator: Haymart, Megan Rist
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.